SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-072599
Filing Date
2023-08-31
Accepted
2023-08-31 07:12:15
Documents
42
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea184381-6k_canfitebio.htm   iXBRL 6-K 25369
2 OPERATING AND FINANCIAL REVIEW AND PROSPECTS AS OF JUNE 30, 2023 ea184381ex99-1_canfitebio.htm EX-99.1 78599
3 UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 202 ea184381ex99-2_canfitebio.htm   iXBRL EX-99.2 236333
4 PRESS RELEASE DATED AUGUST 31, 2023 ea184381ex99-3_canfitebio.htm EX-99.3 61055
  Complete submission text file 0001213900-23-072599.txt   2164677

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE canf-20230630.xsd EX-101.SCH 28828
6 XBRL CALCULATION FILE canf-20230630_cal.xml EX-101.CAL 22621
7 XBRL DEFINITION FILE canf-20230630_def.xml EX-101.DEF 102405
8 XBRL LABEL FILE canf-20230630_lab.xml EX-101.LAB 245430
9 XBRL PRESENTATION FILE canf-20230630_pre.xml EX-101.PRE 110712
36 EXTRACTED XBRL INSTANCE DOCUMENT ea184381-6k_canfitebio_htm.xml XML 154040
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 231226964
SIC: 2834 Pharmaceutical Preparations